ClinicalTrials.gg
RecruitingNCT07838844IASTM-HTUpdated Nov 4, 2026

IASTM vs. Static Stretching for Hamstring Tightness: Short- and Long-Term Effects

An interventional study of Instrument-Assisted Soft Tissue Mobilization and Static Stretching in Hamstring Tightness, sponsored by GÖKHAN MARAŞ. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-04.

Sponsored by GÖKHAN MARAŞ · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Sep 2026; still recruiting 1 month later.
Updated Nov 4, 2026Now RecruitingFirst site in Turkey (Türkiye)+3 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
46
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study compares two treatments for people with tight hamstring muscles (the muscles at the back of the thigh): instrument-assisted soft tissue mobilization (IASTM) and static stretching. Both are commonly used by physical therapists to improve flexibility, but few studies have looked at their effects beyond a few days after treatment ends.

Forty-six adults with hamstring tightness will be randomly assigned to one of two groups. One group will receive IASTM, and the other will receive static stretching. Both treatments will be given 3 times per week for 4 weeks (12 sessions total).

Researchers will measure flexibility (knee extension range of motion), pressure pain threshold, and physical performance (vertical jump and single-leg hop distance) at three time points: before treatment, 3 days after the last session, and 8 weeks after treatment ends. The goal is to find out which treatment provides better short-term and longer-term benefits.

Read the detailed description

Hamstring muscle tightness is a common musculoskeletal condition that can limit hip and knee range of motion, reduce athletic and functional performance, and contribute to other conditions such as patellofemoral pain, patellar tendinopathy, and low back pain. Static stretching has long been used to address hamstring tightness, with systematic reviews suggesting that 6-8 weeks of regular stretching can produce lasting flexibility gains. Instrument-assisted soft tissue mobilization (IASTM) has more recently emerged as an alternative technique, with proposed mechanisms including controlled microtrauma that stimulates an inflammatory response and collagen remodeling in soft tissue.

Most existing studies comparing static stretching and IASTM for hamstring tightness have examined only single-session or short-term (immediate post-treatment) effects. Long-term follow-up data (≥8 weeks) are limited, making it difficult to determine whether treatment-related gains in flexibility, pain sensitivity, and functional performance are sustained over time.

This randomized controlled trial will enroll 46 participants with hamstring tightness, defined as hip flexion range of motion \<65° on the Straight Leg Raise (SLR) test with no neurological signs. Participants will be randomly allocated (computer-generated randomization) to one of two equal groups (n=23 each):

Group 1 (IASTM): Participants will receive instrument-assisted soft tissue mobilization applied to the hamstring muscle group using a stainless-steel instrument, scanning technique, distal-to-proximal direction, for 5 minutes per session.

Group 2 (Static Stretching): Participants will receive manual static stretching of the hamstring muscle group, performed in 5 repetitions of 30 seconds of stretch followed by 30 seconds of rest (5 minutes total per session).

Both interventions will be delivered 3 times per week for 4 weeks (12 sessions total) by a physical therapist with over 10 years of clinical experience in orthopedic rehabilitation and manual therapy.

Outcome assessments will be performed by a blinded assessor independent of treatment delivery, at three time points: baseline (pre-treatment), short-term (3 days after the final session), and long-term (8 weeks after intervention completion). Outcome measures include:

  • Flexibility: knee extension range of motion during 90° hip flexion, measured with a digital inclinometer
  • Pressure pain threshold: measured with a digital algometer over the hamstring muscle bellies (biceps femoris, semitendinosus, semimembranosus)
  • Functional performance: vertical jump height and single-leg hop distance

Statistical analysis will include two-way repeated-measures ANOVA to assess time and group-by-time interaction effects, with Bonferroni-corrected post hoc comparisons where appropriate.

02

Conditions studied

  • Hamstring Tightness

Keywords

  • Hamstring Tightness
  • Instrument-Assisted Soft Tissue Mobilization
  • IASTM
  • Static Stretching
  • Flexibility
  • Pressure Pain Threshold
  • Range of Motion
03

In context

Lead sponsor

This is the only study on the registry with GÖKHAN MARAŞ as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years or older
  • Hamstring tightness, defined as hip flexion range of motion \<65° on the Straight Leg Raise (SLR) test, without neurological signs
  • No diagnosed chronic musculoskeletal or systemic disease
  • Signed form

Exclusion criteria

Exclusion Criteria:

  • Previous trauma or surgical operation involving the lower extremity
  • Neurological symptoms radiating to one or both lower extremities due to hamstring injury, spinal pathology, or sciatic nerve involvement
  • Ankle instability
  • Pregnancy
  • Neurological signs elicited during the Straight Leg Raise (SLR) test
  • Hyperalgesia, hematoma, varicose veins, or active skin infection in the lower extremity
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
46 participants (estimated)

Study arms

  • Experimental
    IASTM

    Participants will receive instrument-assisted soft tissue mobilization (IASTM) applied to the hamstring muscle group using a stainless-steel instrument in a scanning technique, distal-to-proximal direction, for 5 minutes per session, 3 times per week for 4 weeks (12 sessions total).

    Other: Instrument-Assisted Soft Tissue Mobilization

  • Active comparator
    Static Stretching

    Participants will receive manual static stretching of the hamstring muscle group, performed in 5 repetitions of 30 seconds of stretch followed by 30 seconds of rest (5 minutes total per session), 3 times per week for 4 weeks (12 sessions total).

    Other: Static Stretching

Interventions

  • OtherInstrument-Assisted Soft Tissue Mobilization

    Participants will receive instrument-assisted soft tissue mobilization (IASTM) applied to the hamstring muscle group using a stainless-steel instrument in a scanning technique, distal-to-proximal direction, for 5 minutes per session, 3 times per week for 4 weeks (12 sessions total).

  • OtherStatic Stretching

    Participants will receive manual static stretching of the hamstring muscle group, performed in 5 repetitions of 30 seconds of stretch followed by 30 seconds of rest (5 minutes total per session), 3 times per week for 4 weeks (12 sessions total).

06

What researchers measure

Primary outcomes

  1. Change in Knee Extension Range of Motion (Flexibility)

    Knee extension range of motion during 90° hip flexion, measured with a digital inclinometer, as an indicator of hamstring flexibility.

    Time frame: Baseline, 3 days after final session (short-term), and 8 weeks after intervention completion (long-term)

07

Study locations

1 of 1 sites recruiting
  • Selcuk University, Kulu Faculty of Health Sciences
    Kulu, Konya, Turkey (Türkiye)
    Recruiting
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Started Sep 2026 (actual). Primary completion is estimated for Dec 2026, 3 months after the start.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 4, 2026: primary completion Feb 2027 → Dec 2026 and completion Feb 2027 → Dec 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Sep 18, 2026
First posted
Sep 24, 2026
StartActual
Sep 22, 2026
Primary completionEst.
Dec 31, 2026was Feb 2027
CompletionEst.
Dec 31, 2026was Feb 2027
Last update
Nov 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 4, 2026
Sites
1 site added — first site in Turkey (Türkiye)
Show site
  • Selcuk University, Kulu Faculty of Health Sciences · Kulu, Turkey (Türkiye)
Nov 4, 2026
Primary completion
Feb 2027→Dec 31, 2026
Nov 4, 2026
Study completion
Feb 2027→Dec 31, 2026
Nov 4, 2026
Show all 1 update
  1. Nov 4, 2026
    Not yet recruiting→Recruiting
    1 site added — first site in Turkey (Türkiye)
    Show site
    • Selcuk University, Kulu Faculty of Health Sciences · Kulu, Turkey (Türkiye)
    Primary completion Feb 2027→Dec 31, 2026
    Study completion Feb 2027→Dec 31, 2026
    + 2 other changes: verification date and responsible party

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07838844
Lead sponsor
GÖKHAN MARAŞ
Responsible party
GÖKHAN MARAŞ (Assistant Professor, Gazi University) — Sponsor-investigator
First posted
Sep 24, 2026
Start date
Sep 22, 2026
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Nov 4, 2026

Study contacts

Gokhan Maras, PT, PhD
Contact
gokhan.maras@selcuk.edu.tr
+90 542 785 9619
Gokhan Maras, PT, PhD
principal investigator · Selcuk University, Kulu Faculty of Health Sciences

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion